troet.cafe ist Teil eines dezentralisierten sozialen Netzwerks, angetrieben von Mastodon.
Hallo im troet.cafe! Dies ist die derzeit größte deutschsprachige Mastodon Instanz zum tröten, neue Leute kennenlernen, sich auszutauschen und Spaß zu haben.

Verwaltet von:

Serverstatistik:

6,9 Tsd.
aktive Profile

Mehr erfahren

#ecigs

0 Beiträge0 Beteiligte0 Beiträge heute
Antwortete Dr Joe Pajak

'New research warns that vaping during pregnancy isn't as safe as many believe - nicotine, toxic aerosols, and oxidative stress could put newborns at risk for lifelong lung issues'.
@newsmedical.bsky.social
🚭👶🫁 #ECigs #Pregnancy
🔗 mdpi.com/2076-3921/14/3/262
🔗 news-medical.net/news/20250227

MDPIImpact of E-Cigarettes on Fetal and Neonatal Lung Development: The Influence of Oxidative Stress and InflammationElectronic cigarettes (e-cigs) recently increased their popularity as “safer” alternatives to traditional tobacco smoking, including among pregnant women. However, the effect of e-cig exposure on fetal and neonatal developing lungs remains poorly investigated. In this review, we analysed the impact of e-cig aerosol components (e.g., nicotine, solvents, and flavouring agents) on respiratory system development. We particularly emphasized the role of e-cig-related oxidative stress and inflammation on lung impairment. Nicotine contained in e-cigs can impair lung development at anatomical and molecular levels. Solvents and flavours induce inflammation and oxidative stress and contribute to compromising neonatal lung function. Studies suggest that prenatal e-cig aerosol exposure may increase the risk of future development of respiratory diseases in offspring, such as asthma and chronic obstructive pulmonary disease (COPD). Preventive strategies, such as smoking cessation programs and antioxidant supplementation, may be essential for safeguarding respiratory health. There is an urgent need to explore the safety profile and potential risks of e-cigs, especially considering the limited studies in humans. This review highlights the necessity of regulating e-cig use during pregnancy and promoting awareness of its potential consequences on fetal and neonatal development.

EU-Rat der Gesundheitsminister nimmt gegen die Entscheidung des EU-Parlaments, die Empfehlung der EU-Kommission zu Rauch- und Dampfverbote unter freiem Himmel an.

tinyurl.com/f7bjdpy3

Jetzt kommt es darauf an, was die EU-Mitgliedsstaaten daraus machen.

DampfFreiheit · [EU] EU-Rat für Gesundheit nimmt Empfehlung für Rauch- und Dampfverbote an - DampfFreiheitDie Empfehlung der EU-Kommission für Rauch- und Dampfverbote wurde durch EU-Rat der Gesundheitsminister angenommen.
#ezigarette#edampfe#dampfen

Oha, jetzt werden Dampferforen durchsucht um kostenloses Studienmaterial zu erhalten.

Hier in Bezug auf das Dampfverhalten:

pmc.ncbi.nlm.nih.gov/articles/

Das finde ich nicht gut.

Ja, mag sein, dass das Verhalten beim Dampfen ähnlich zum Rauchen ist das ist genau der Vorteil: Habitus dem Rauchen ähnlich aber ohne diese gefährlichen Schadstoffe inkl. meist mit einhergehenden Rauchstopp!
Ziel erreicht.

PubMed Central (PMC)„Dauernuckler“ oder „Genussdampfer“? Eine netnographische Analyse selbstberichteter Anzeichen möglicher Abhängigkeitssymptome in E-Zigaretten-Online-Foren
#ezigarette#edampfe#dampfen

Kohortenstudie zur Nutzung von E-Dampfprodukte:

"Das Querschnittsdesign dieser Studie kann keinen Kausalzusammenhang zwischen E-Zigarettenkonsum und Atemwegssymptomen herstellen."

nature.com/articles/s41598-024

NatureRespiratory symptoms among e-cigarette users without an established smoking history in the VERITAS cohort - Scientific ReportsPrior research on e-cigarettes’ health impacts is inconclusive due to confounding by previous tobacco smoking. Studies of e-cigarette use among people without an established smoking history are informative for this question. A cross-sectional survey was administered across six geopolitical world regions to adults aged 18+ without a history of established cigarette smoking or regular use of other nicotine/tobacco products. Two cohorts were defined based on e-cigarette use: “Vapers Cohort” (N = 491) who used e-cigarettes in the past 7 days and “Control Cohort” (N = 247) who never regularly used e-cigarettes. Frequency of respiratory symptoms (Respiratory Symptom Evaluation Score (RSES)) were compared between cohorts, adjusting for sociodemographics. Tobacco use history and patterns of e-cigarette use was also examined. Respiratory symptoms were rare among both the Vapers and Control Cohorts: 83.3% and 88.4%, respectively, reported “rarely” or “never” experiencing all five RSES items (p = 0.125). The Vapers (vs. Control) Cohort reported modestly more frequent respiratory symptoms (adjusted mean RSES 1.61 vs. 1.43, respectively, p < 0.001); however, this difference (0.18) did not reach the threshold of clinical relevance (0.57). The Vapers (vs. Control) Cohort more often reported former cigarette experimentation (30.8% vs. 12.1%) and former infrequent use of other nicotine/tobacco products (18.1% vs. 5.8%). The Vapers Cohort most often used disposable devices (63.7%) and multiple flavors (approximately 70–80% across primary device type). In this cohort of adults without a history of established combustible tobacco use, e-cigarette use was statistically linked to more frequent respiratory symptoms, though not in a clinically meaningful way. The cross-sectional design of this study cannot establish causality between e-cigarette use and respiratory symptoms.
#ezigarette#edampfe#dampfen